MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma

PY Wen, 2008, Malignant gliomas in adults, N Engl J Med, 359, 492, 10.1056/NEJMra0708126

AJ Gabayan, 2006, GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis, Neurosurgery, 58, 701, 10.1227/01.NEU.0000194836.07848.69

M Esteller, 2011, Non-coding RNAs in human disease, Nat Rev Genet, 12, 861, 10.1038/nrg3074

DP Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5

BM Ryan, 2010, Genetic variation in microRNA networks: the implications for cancer research, Nat Rev Cancer, 10, 389, 10.1038/nrc2867

J Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702

F Zhi, 2010, The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma, Eur J Cancer, 46, 1640, 10.1016/j.ejca.2010.02.003

ZM Shi, 2013, MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas, RNA, 19, 552, 10.1261/rna.035972.112

J Wang, 2013, miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1, Cancer Chemother Pharmacol, 72, 147, 10.1007/s00280-013-2180-3

F Zhi, 2013, miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK, PLoS One, 8, e72390, 10.1371/journal.pone.0072390

BP Lewis, 2003, Prediction of mammalian microRNA targets, Cell, 115, 787, 10.1016/S0092-8674(03)01018-3

A Krek, 2005, Combinatorial microRNA target predictions, Nat Genet, 37, 495, 10.1038/ng1536

B John, 2004, Human MicroRNA targets, PLoS Biol, 2, e363, 10.1371/journal.pbio.0020363

F Zhi, 2012, Activated beta-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma, Int J Biol Sci, 8, 289, 10.7150/ijbs.3520

GA Calin, 2006, MicroRNA signatures in human cancers, Nat Rev Cancer, 6, 857, 10.1038/nrc1997

DH Chitwood, 2010, Small RNAs are on the move, Nature, 467, 415, 10.1038/nature09351

L He, 2013, MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3, Genet Mol Res, 12, 1012, 10.4238/2013.April.2.17

JX Guo, 2012, miR-181b as a potential molecular target for anticancer therapy of gastric neoplasms, Asian Pac J Cancer Prev, 13, 2263, 10.7314/APJCP.2012.13.5.2263

A Bisso, 2013, Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer, Cell Cycle, 12, 1679, 10.4161/cc.24757

Y Lu, 2011, Anti-microRNA-222 (anti-miR-222) and -181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal, J Biol Chem, 286, 42292, 10.1074/jbc.M111.270926

L Chen, 2012, MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas, IUBMB Life, 64, 628, 10.1002/iub.1030

D Takiuchi, 2013, Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells, Pancreatology, 13, 517, 10.1016/j.pan.2013.06.007

B Cai, 2013, miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2, Oncol Rep, 29, 1769, 10.3892/or.2013.2297

A Ratti, 2008, Post-transcriptional Regulation of Neuro-oncological Ventral Antigen 1 by the Neuronal RNA-binding Proteins ELAV, Journal of Biological Chemistry, 283, 7531, 10.1074/jbc.M706082200

J Ule, 2006, An RNA map predicting Nova-dependent splicing regulation, Nature, 444, 580, 10.1038/nature05304

BK Dredge, 2005, Nova autoregulation reveals dual functions in neuronal splicing, EMBO J, 24, 1608, 10.1038/sj.emboj.7600630

E Park, 2011, Regulatory roles of heterogeneous nuclear ribonucleoprotein M and Nova-1 protein in alternative splicing of dopamine D2 receptor pre-mRNA, J Biol Chem, 286, 25301, 10.1074/jbc.M110.206540

M Ruggiu, 2009, Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing, Proceedings of the National Academy of Sciences, 106, 3513, 10.1073/pnas.0813112106

H Li, 2013, Dynamic expression pattern of neuro-oncological ventral antigen 1 (Nova1) in the rat brain after focal cerebral ischemia/reperfusion insults, J Histochem Cytochem, 61, 45, 10.1369/0022155412461255

C Zhang, 2010, Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls, Science, 329, 439, 10.1126/science.1191150

J Ule, 2005, Nova regulates brain-specific splicing to shape the synapse, Nat Genet, 37, 844, 10.1038/ng1610